Changes in the Cutaneous Nerve Fiber Staining and Distribution of PGP9.5 in Clinically Uninvolved Skin in Leprosy Patients after Completion of Multidrug Therapy and Assessing PGP9.5 as a Marker of Treatment Response
Background: Subclinical involvement of nerves may sometimes be present much before the overt clinical manifestations become apparent. Protein gene product (PGP) 9.5, a ubiquitin-C-terminal hydrolase, has been widely used as a marker to study the involvement of peripheral nerve fibers in many disease...
Saved in:
Main Authors: | Vishal Thakur (Author), Tarun Narang (Author), Anuradha Bishnoi (Author), Garima Dhawan (Author), Ankur Sharma (Author), Uma Nahar Saikia (Author), T Muhammad Razmi (Author), Sunil Dogra (Author), Sanjeev Handa (Author), Manish Modi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ACTH6-9-PGP improves memory consolidation processes in rats
by: Svetlana A. Dodonova, et al.
Published: (2021) -
CT694 and pgp3 as serological tools for monitoring trachoma programs.
by: E Brook Goodhew, et al.
Published: (2012) -
Optimised paediatric antiretroviral treatment to achieve the 95-95-95 goals
by: Moherndran Archary, et al.
Published: (2021) -
CLINICAL AND IMMUNOLOGIC IMPORTANCE OF MDR1/PGP 170 EXPRESSION IN PATIENTS WITH BREAST CANCER
by: D. A. Yengay, et al.
Published: (2014) -
The multidrug resistance proteins Pgp, MRP, and BCRP as markers for lowering the efficacy of tamoxifen in the treatment of breast cancer
by: T. A. Bogush, et al.
Published: (2014)